You are using an older browser version. Please use a supported version for the best MSN experience.

Lilly says antibody drug cuts COVID-19 risk for nursing home residents

A trial of Eli Lilly's antibody drug shows it can reduce the risk of COVID-19 by 80% for nursing home residents, the company said on Thursday, although the need for such disease prevention tools has dwindled as vaccines become available. This report produced by Jillian Kitchener.
image beaconimage beaconimage beacon